Plunkett Research Online: Cocrystal Pharma Inc

COCRYSTAL PHARMA INC (COCP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cocrystal Pharma, Inc. is a clinical-stage biopharmaceutical company. The firm develops novel technologies and strives to create first-in-class or best-in-class antiviral drug candidates that will transform the treatment and prophylaxis of viral diseases in humans. Cocrystal focuses its research a.....



Cocrystal Pharma Inc
Ticker: COCP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 786-459-1831
Fax:
Address: 19805 North Creek Parkway
Bothell, WA 98011 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Clinical-Stage Biopharmaceuticals
Therapeutic Development
Antiviral Drug Candidates
Viral Replication Inhibitors
Contacts Description

James Martin CFO/Chief Accounting Officer
Jane Hsiao Director
See More
Cocrystal Pharma, Inc. is a clinical-stage biopharmaceutical company. The firm develops novel technologies and strives to create first-in-class or best-in-class antiviral drug candidates that will transform the treatment and prophylaxis of viral diseases in humans. Cocrystal focuses its research a.....See More See More

Auditor: Weinberg & Company
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: